EA202193146A1 - Противогрибковые агенты для деколонизации candida auris - Google Patents
Противогрибковые агенты для деколонизации candida aurisInfo
- Publication number
- EA202193146A1 EA202193146A1 EA202193146A EA202193146A EA202193146A1 EA 202193146 A1 EA202193146 A1 EA 202193146A1 EA 202193146 A EA202193146 A EA 202193146A EA 202193146 A EA202193146 A EA 202193146A EA 202193146 A1 EA202193146 A1 EA 202193146A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- candida auris
- decolonization
- enfumafungin
- decolonize
- subjects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Тритерпеноидные противогрибковые соединения, являющиеся производными энфумафунгина, применяют для деколонизации грибков из анатомических областей субъектов, колонизированных грибками. Тритерпеноидные производные энфумафунгина (или их фармацевтически приемлемые соли или гидраты) являются ингибиторами синтеза (1,3)--D-глюкана и могут деколонизировать Candida auris с таких участков тела, как кожа и слизистые оболочки. Субъекты, которым будет полезна данная деколонизация, включают людей, колонизированных Candida auris, которые ранее перенесли инфекцию Candida auris и склонны к рецидиву и/или могут передавать грибок другим индивидам, которые могут быть восприимчивыми.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962849019P | 2019-05-16 | 2019-05-16 | |
PCT/US2020/032547 WO2020232037A1 (en) | 2019-05-16 | 2020-05-12 | Antifungal agents, like ibrexafungerp for candida auris decolonization |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202193146A1 true EA202193146A1 (ru) | 2022-02-11 |
Family
ID=70861571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202193146A EA202193146A1 (ru) | 2019-05-16 | 2020-05-12 | Противогрибковые агенты для деколонизации candida auris |
Country Status (14)
Country | Link |
---|---|
US (1) | US20220211684A1 (ru) |
EP (1) | EP3968986A1 (ru) |
JP (1) | JP2022532734A (ru) |
KR (1) | KR20220009416A (ru) |
CN (1) | CN113905733A (ru) |
AU (1) | AU2020276595A1 (ru) |
BR (1) | BR112021022876A2 (ru) |
CA (1) | CA3140637A1 (ru) |
EA (1) | EA202193146A1 (ru) |
IL (1) | IL288165A (ru) |
MA (1) | MA55958A (ru) |
MX (1) | MX2021013899A (ru) |
TW (1) | TW202110441A (ru) |
WO (1) | WO2020232037A1 (ru) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
WO2007127012A1 (en) | 2006-04-03 | 2007-11-08 | Merck & Co., Inc. | Antifungal agents |
RS53731B1 (en) * | 2008-08-12 | 2015-06-30 | Scynexis, Inc. | ANTIGLIVIC AGENTS |
CN102176827B (zh) | 2008-08-12 | 2015-05-20 | 西尼克斯公司 | 抗真菌制剂 |
MA43825A (fr) * | 2016-03-16 | 2021-04-07 | Cidara Therapeutics Inc | Schémas posologiques pour le traitement d'infections fongiques |
JP7263313B2 (ja) * | 2017-04-10 | 2023-04-24 | サイネクシス,インコーポレーテッド | 併用される抗真菌剤 |
US20200291488A1 (en) * | 2017-05-17 | 2020-09-17 | T2 Biosystems, Inc. | Nmr methods and systems for the rapid detection of candida species |
WO2019028034A1 (en) * | 2017-08-04 | 2019-02-07 | Scynexis, Inc. | ANTIFUNGAL AGENTS WITH IMPROVED PH ACID ACTIVITY |
EA202192107A1 (ru) * | 2019-01-30 | 2021-10-21 | Сайнексис, Инк. | Тритерпеноидные фунгициды для лечения грибковых костно-суставных инфекций |
-
2020
- 2020-05-12 AU AU2020276595A patent/AU2020276595A1/en active Pending
- 2020-05-12 WO PCT/US2020/032547 patent/WO2020232037A1/en active Application Filing
- 2020-05-12 MA MA055958A patent/MA55958A/fr unknown
- 2020-05-12 JP JP2021568113A patent/JP2022532734A/ja active Pending
- 2020-05-12 KR KR1020217040747A patent/KR20220009416A/ko unknown
- 2020-05-12 EP EP20728876.2A patent/EP3968986A1/en active Pending
- 2020-05-12 BR BR112021022876A patent/BR112021022876A2/pt unknown
- 2020-05-12 CN CN202080041224.0A patent/CN113905733A/zh active Pending
- 2020-05-12 US US17/610,440 patent/US20220211684A1/en active Pending
- 2020-05-12 CA CA3140637A patent/CA3140637A1/en active Pending
- 2020-05-12 EA EA202193146A patent/EA202193146A1/ru unknown
- 2020-05-12 MX MX2021013899A patent/MX2021013899A/es unknown
- 2020-05-15 TW TW109116151A patent/TW202110441A/zh unknown
-
2021
- 2021-11-16 IL IL288165A patent/IL288165A/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20220009416A (ko) | 2022-01-24 |
MA55958A (fr) | 2022-03-23 |
TW202110441A (zh) | 2021-03-16 |
AU2020276595A1 (en) | 2021-12-09 |
BR112021022876A2 (pt) | 2022-04-12 |
EP3968986A1 (en) | 2022-03-23 |
CN113905733A (zh) | 2022-01-07 |
US20220211684A1 (en) | 2022-07-07 |
MX2021013899A (es) | 2022-02-10 |
CA3140637A1 (en) | 2020-11-19 |
IL288165A (en) | 2022-01-01 |
WO2020232037A1 (en) | 2020-11-19 |
JP2022532734A (ja) | 2022-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4331677A3 (en) | Methods of treating feline coronavirus infections | |
MX2022006663A (es) | Compuesto heterociclico que contiene oxigeno, metodo de preparacion de este y uso de este. | |
BR112018074268A2 (pt) | pastas dentais terapêuticas e métodos e kits relacionados | |
EA202193015A1 (ru) | Ингибиторы cdk | |
MX2017012393A (es) | Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico. | |
MX2024000299A (es) | Compuestos antivirales. | |
CL2023000069A1 (es) | Mezclas fungicidas | |
EP4233865A3 (en) | Aryl-aniline and heteroaryl-aniline compounds for treatment of skin cancers | |
EP4249071A3 (en) | Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase | |
MX2021012105A (es) | Compuestos de pirrol. | |
MX2019006768A (es) | Peptidos antimicrobianos. | |
AU2020231934A8 (en) | Compounds useful in HIV therapy | |
EA201992090A1 (ru) | ДЕЙТЕРИРОВАННЫЕ СОЕДИНЕНИЯ ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА | |
PH12020551772A1 (en) | Oxo-substituted compound | |
MX2020008982A (es) | Compuestos de 4-metildihidropirimidinona y su uso farmaceutico. | |
UA113749C2 (xx) | Композиція для назального застосування з покращеною стабільністю | |
PH12019500849A1 (en) | Naphthyridinone derivatives and their use inthe treatment of arrhythmia | |
PH12020552186A1 (en) | Cyanotriazole compounds and uses thereof | |
MX2024005107A (es) | Nuevo uso de compuesto de quinazolinona para el tratamiento de cancer. | |
EA202290019A1 (ru) | Фунгицидная композиция для борьбы с инфекцией, вызываемой грибом zymoseptoria, у растений | |
CR20190545A (es) | Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias | |
EA202193146A1 (ru) | Противогрибковые агенты для деколонизации candida auris | |
MX2022003845A (es) | Tratamientos cognitivos medicinales. | |
BR112023019657A2 (pt) | Antagonista de abhd6 | |
BR112022024988A2 (pt) | Compostos e métodos para tratamento de infecções fúngicas |